Mesa Verde Venture Partners IV, LP
Late investment periodEmerging manager
Late investment period: first sale Feb 2022, per Form D (fund age approximates vintage)
- Vintage
- 2022
- Fund size
- $7.58M (Form D)
- Stages
- Not stated
- Sectors
- Biotech, Medical devices, Life sciences and research tools, Digital health
- Regions
- CA
01 · Thesis
No thesis found on the firm's website yet.
02 · Initial check
$76K to $126K (estimated from fund size)
Estimated from Form D
03 · Who to approach
Named on this fund's Form D
- Fred Middleton, MBA, Managing Director
- Carey Ng, PhD, MBA, Managing Director
- Francois Ferre, PhD, Managing Director
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
Firm-wideMesa Verde Venture Partners is an early-stage life sciences venture capital firm focused on creating partnerships with entrepreneurs to build successful companies.
Mesa Verde Venture Partners is an early-stage life sciences venture capital firm focused on creating partnerships with entrepreneurs to build successful companies.
https://www.mesaverdevp.com/
06 · Sources
Last verified: Oct 28, 2026